EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Predictors of Hepatic Decompensation after Yttrium90 Transarterial Radioembolization—Optimizing Patient Selection

Amelia Wong, Shirley Cheng, Anthony Herrera, Linda Wong

Journal of Clinical Interventional Radiology ISVIR · 01.08.2024 · 08 (02) · 083-089

DOI: 10.1055/s-0044-1786711 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Interventional Radiology ISVIR, erschienen am 01.08.2024. Verfasst von Amelia Wong und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Yttrium 90 (Y90) transarterial radioembolization (TARE) is effective for unresectable hepatocellular carcinoma (HCC) or to bridge/downstage before transplant; however, optimal patient selection is not well-described. This study aims to identify factors that increase risk of liver decompensation resulting in hospital admissions after TARE.

Methods

Patients who received Y90 as their first treatment during 2012 to 2022 were identified from a prospectively collected database of 1675 HCC patients. Clinically significant hepatic decompensation was defined as total bilirubin more than or equal to 3 mg/dL or any increase in Model for End-stage Liver Disease (MELD) score resulting in readmission within 60 days or death.

Results

Of 137 patients, 7 (5.1%) developed hepatic decompensation requiring admission within 30 days and an additional 8 (10.9%) within 60 days. Two of these patients (1.4%) died and two (1.4%) required urgent transplant within 2 months. Preprocedure albumin less than 3.5 gm/dL (p = 0.0207), international normalized ratio more than 1.2 (p = 0.017), ascites (p = 0.036), elevated MELD (p = 0.012), and Child-Pugh (p = 0.007) scores were significant predictors of decompensation, while creatinine and sodium were not. Patients with Child-Pugh B score were three to four times more likely to decompensate (28 vs. 8%) compared to Child-Pugh A. For every unit increase in Child-Pugh score more than 6, odds of decompensation increased by a factor of 2.15.

Conclusion

Y90 TARE is safe and effective; however, 10.9% patients require readmission for worsened liver function. Because ascites is a significant factor in predicting decompensation and all patients require adequate renal function to receive Y90 TARE, Child-Pugh score may be more useful than MELD for patient selection. Further risk stratification may be required for those with a Child-Pugh score more than or equal to 7.

Zitieren

APA

Wong, A., Cheng, S., Herrera, A., & Wong, L. (2024). Predictors of Hepatic Decompensation after Yttrium90 Transarterial Radioembolization—Optimizing Patient Selection. Journal of Clinical Interventional Radiology ISVIR, 08(02), 083-089. https://doi.org/10.1055/s-0044-1786711

Vancouver

Wong A, Cheng S, Herrera A, Wong L. Predictors of Hepatic Decompensation after Yttrium90 Transarterial Radioembolization—Optimizing Patient Selection. Journal of Clinical Interventional Radiology ISVIR. 2024;08(02):083-089. doi:10.1055/s-0044-1786711

BibTeX
@article{Wong2024,
  author = {Wong, Amelia and Cheng, Shirley and Herrera, Anthony and Wong, Linda},
  title = {Predictors of Hepatic Decompensation after Yttrium90 Transarterial Radioembolization—Optimizing Patient Selection},
  journal = {Journal of Clinical Interventional Radiology ISVIR},
  year = {2024},
  volume = {08},
  number = {02},
  pages = {083--089},
  doi = {10.1055/s-0044-1786711}
}
Kostenlos starten →